Cell & Gene Companies
We bring specialized expertise tailored to the unique and complex needs of cell and gene therapy supply chains.
Why Clients Need AIM
Cell & gene therapies are novel and highly complex, often with challenging supply chain requirements:
- Complex manufacturing
- Highly specific packaging and labeling
- JIT management practices
- Special handling
- Significant data protection, tracking, and documentation
- Special training and licensing
- Substantial customer / administrator training and on-boarding
- Specialized order-to-cash processes
A specialized guide is essential to success in this complex space.
The AIM Difference
- Unmatched track record launching all types of cell and gene therapies
- In-depth experience orchestrating all key elements across the clinical and commercial supply chains
- Operational experience with ensuring a seamless transition from the clinical to commercial stage
- In-depth knowledge of the evolving universe of third-party vendors in the space
Services
Consulting
Strategic and tactical consulting to improve operations or tackle new supply chain challenges
Interim Professionals
Experienced professionals who can provide specific expertise or leadership when critical roles are temporarily vacant
Resources
April 12, 2024
Moving from Clinical to Commercial in Cell & Gene Therapies: Supply Chain Considerations
Read MoreCase Studies
See how we’ve delivered customized solutions that enhance operational efficiency and business growth for our clients.
View Case StudiesWe are a collaborative team of more than 50 supply chain experts.
see the aim differenceContact
AIM Today
If you have a question or would like to schedule an introductory conversation, then please complete a short contact form.
